Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-13

Clinical Trial Update: Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

View source ↗

Summary

A long-term non-interventional study assessed the safety and effectiveness of Macugen in patients with neovascular age-related macular degeneration under routin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Age-related Macular Degeneration | Status: COMPLETED | Results posted: 2013-08-13